Penserra Capital Management LLC lifted its position in shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report) by 3.0% in the second quarter, Holdings Channel reports. The institutional investor owned 1,157,004 shares of the company’s stock after acquiring an additional 34,191 shares during the period. Penserra Capital Management LLC’s holdings in BlackRock Health Sciences Term Trust were worth $16,498,000 as of its most recent filing with the SEC.
A number of other institutional investors also recently modified their holdings of the business. CWM LLC increased its position in BlackRock Health Sciences Term Trust by 177.9% during the first quarter. CWM LLC now owns 2,596 shares of the company’s stock worth $39,000 after acquiring an additional 1,662 shares during the period. Larson Financial Group LLC grew its position in shares of BlackRock Health Sciences Term Trust by 51.9% during the 1st quarter. Larson Financial Group LLC now owns 2,050 shares of the company’s stock worth $31,000 after purchasing an additional 700 shares in the last quarter. Tabor Asset Management LP bought a new position in shares of BlackRock Health Sciences Term Trust during the first quarter worth approximately $3,268,000. Wedbush Securities Inc. raised its position in shares of BlackRock Health Sciences Term Trust by 68.8% in the first quarter. Wedbush Securities Inc. now owns 36,210 shares of the company’s stock valued at $540,000 after buying an additional 14,757 shares in the last quarter. Finally, LPL Financial LLC boosted its stake in shares of BlackRock Health Sciences Term Trust by 2.3% in the first quarter. LPL Financial LLC now owns 195,565 shares of the company’s stock valued at $2,914,000 after buying an additional 4,397 shares during the period.
BlackRock Health Sciences Term Trust Price Performance
Shares of NYSE:BMEZ opened at $14.66 on Friday. The business’s 50 day simple moving average is $14.65 and its 200 day simple moving average is $14.41. BlackRock Health Sciences Term Trust has a 1 year low of $12.58 and a 1 year high of $16.75.
BlackRock Health Sciences Term Trust Announces Dividend
About BlackRock Health Sciences Term Trust
BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.
See Also
- Five stocks we like better than BlackRock Health Sciences Term Trust
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Rivian’s Chart Says Go, But Some Analysts Still Say No
- Roth IRA Calculator: Calculate Your Potential Returns
- e.l.f. Sell-Off Is a Good Time to Buy, According to Analysts
- Pets Are Big Business: 4 Big-Ticket Pet Stocks to Add to Your Portfolio
- T-Mobile Is The Most Oversold Mega-Cap Stock—Time to Buy?
Want to see what other hedge funds are holding BMEZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report).
Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.
